Europe holds the largest share of the global green chelates natural chelating agents market, 32% of 2025 revenue at USD 0.656 billion, and is projected to reach USD 1.154 billion by 2034, according to Contrive Datum Insights.
Market size and regional comparison
The global market was valued at USD 2.05 billion in 2025. It is projected to rise from USD 2.19 billion in 2026 to USD 3.98 billion by 2034, a compound annual growth rate of 7.75% over the forecast period. Contrive Datum Insights presents these findings in its report on the green chelates natural chelating agents market, which covers type, application, source, form, distribution channel and region.
Green chelates are biodegradable chelating agents made from renewable feedstocks such as glucose, corn starch or amino acids. Formulators use them in place of conventional synthetic chelators like EDTA to bind and stabilize metal ions in cleaning, water treatment, agricultural fertilizer, personal care and food processing. Buyers range from large multinational formulators on long-term supply contracts to smaller regional producers buying through distributors.
Asia Pacific is the region closing in. Its share climbs from 27% of revenue in 2025 to 33% in 2034, as revenue grows from USD 0.554 billion to USD 1.313 billion. Middle East and Africa stays the smallest region at 6% in both years. The United States is the largest single country market, at USD 0.448 billion in 2025, or 21.85% of global revenue.
Segments and the risk to Europe's lead
By type, Sodium Gluconate held 38% of 2025 revenue, worth USD 0.779 billion, yet it grows at 5.69%, below the market's pace. MGDA is the fastest type line at 10.88%, lifting its share of revenue from 20% to 26% and its value from USD 0.41 billion to USD 1.035 billion. Regulatory phase-out of phosphates and EDTA in formulated products is the largest single contributor to growth, and the study rates its impact high.
Most other axes show a large incumbent beside a quicker challenger. Cleaning led applications in 2025 with 30% of revenue at USD 0.615 billion, while Agriculture grows fastest at 9.52%. Fermentation-derived material led by source with 45% of revenue, or USD 0.923 billion. Liquid took 62% of revenue by form, with Powder/Granules growing fastest at 8.27%. Direct/B2B Sales carried 68% of channel revenue, and Distributors & Retailers grow fastest at 8.38%.
Europe's lead is not fixed. Asia Pacific's 33% share in 2034 would sit above the 32% Europe holds in 2025, and the pace of regulation shapes how quickly that gap closes. In the bull case, faster restriction of conventional synthetic chelators across major markets accelerates formulator switching and pulls forward fermentation capacity investment, taking 2034 revenue to USD 4.458 billion. Slower enforcement and continued price competition from lower-cost conventional chelators would delay reformulation timelines and slow capacity additions, holding 2034 revenue to USD 3.582 billion.
The report provides revenue and a growth rate for every line in every year from 2020 to 2034, covers all five regions with country-level breakdowns, and sets out the competitive landscape and research methodology. It is delivered as a PDF; a free sample is available on request.